PsyBio Therapeutics Initiates European Manufacturing of Proprietary Biosynthetic Psychedelic Compounds including… Jun 22, 2021
PharmaDrug Advances Product and Clinical Development of Cepharanthine to Treat Infectious Diseases Including COVID-19 Jun 22, 2021
Revive Collaborates With University of Health Sciences Antigua To Pioneer Clinical Research of Psychedelic Jun 17, 2021
MINDCURE Develops Proprietary Ketamine-Enhanced Psychotherapy Protocols for Treatment of Pain and Depression Jun 17, 2021